An immunohistochemistry and histopathological study of ankaferd blood stopper in a rat model of cervical inflammation
OBJECTIVE: Ankaferd Blood Stopper (ABS) is a medicinal plant extract used topically as a hemostatic, anti-inflammatory, and anti-oxidant agent. Its cytoprotective effect mainly depends on its pleiotropic properties by modulating inflammatory mediators such as IL-1β, IL-6, and TNF-α. This study aims to test the possible therapeutic effect of ABS in the treatment of erosive and inflammatory conditions occurring in the uterine cervix.
METHODS: Twenty-four female Wistar Albino rats were used in the present study. Trichloracetic acid was applied intravaginally to establish an experimental rat model of cervicitis. The rats were randomly divided into three groups: group I (injury), group II (injury+isotoinc saline), and group III (injury+ABS). After 3 estrous cycles of ABS and isotonic saline treatment, the amount of inflammation, vascular congestion and erosion were evaluated in the cervical tissues by using a modified semi-quantitative scale of 0-3. Immunohistochemical staining with monoclonal antibodies against IL-1β was also performed.
RESULTS: Compared with group I and II, the ABS group showed the least inflammatory cell infiltration, vascular congestion and cervical erosion, compared with the ABS group prominent IL-1β staining observed in group I and group II.
CONCLUSION: Our data suggest that ABS is a highly effective alternative to induce normal cervical epithelium and can be used safely in the treatment of cervical inflammation with or without cervical erosion.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:65 |
---|---|
Enthalten in: |
Revista da Associacao Medica Brasileira (1992) - 65(2019), 2 vom: 14. Feb., Seite 183-190 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Beyazit, Fatma [VerfasserIn] |
---|
Links: |
---|
Themen: |
Ankaferd blood stopper |
---|
Anmerkungen: |
Date Completed 03.04.2019 Date Revised 03.04.2019 published: Print Citation Status MEDLINE |
---|
doi: |
10.1590/1806-9282.65.2.183 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM295152192 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM295152192 | ||
003 | DE-627 | ||
005 | 20231225083030.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1590/1806-9282.65.2.183 |2 doi | |
028 | 5 | 2 | |a pubmed24n0983.xml |
035 | |a (DE-627)NLM295152192 | ||
035 | |a (NLM)30892442 | ||
035 | |a (PII)S0104-42302019000200183 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Beyazit, Fatma |e verfasserin |4 aut | |
245 | 1 | 3 | |a An immunohistochemistry and histopathological study of ankaferd blood stopper in a rat model of cervical inflammation |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.04.2019 | ||
500 | |a Date Revised 03.04.2019 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: Ankaferd Blood Stopper (ABS) is a medicinal plant extract used topically as a hemostatic, anti-inflammatory, and anti-oxidant agent. Its cytoprotective effect mainly depends on its pleiotropic properties by modulating inflammatory mediators such as IL-1β, IL-6, and TNF-α. This study aims to test the possible therapeutic effect of ABS in the treatment of erosive and inflammatory conditions occurring in the uterine cervix | ||
520 | |a METHODS: Twenty-four female Wistar Albino rats were used in the present study. Trichloracetic acid was applied intravaginally to establish an experimental rat model of cervicitis. The rats were randomly divided into three groups: group I (injury), group II (injury+isotoinc saline), and group III (injury+ABS). After 3 estrous cycles of ABS and isotonic saline treatment, the amount of inflammation, vascular congestion and erosion were evaluated in the cervical tissues by using a modified semi-quantitative scale of 0-3. Immunohistochemical staining with monoclonal antibodies against IL-1β was also performed | ||
520 | |a RESULTS: Compared with group I and II, the ABS group showed the least inflammatory cell infiltration, vascular congestion and cervical erosion, compared with the ABS group prominent IL-1β staining observed in group I and group II | ||
520 | |a CONCLUSION: Our data suggest that ABS is a highly effective alternative to induce normal cervical epithelium and can be used safely in the treatment of cervical inflammation with or without cervical erosion | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Interleukin-6 |2 NLM | |
650 | 7 | |a Plant Extracts |2 NLM | |
650 | 7 | |a Tumor Necrosis Factor-alpha |2 NLM | |
650 | 7 | |a ankaferd blood stopper |2 NLM | |
700 | 1 | |a Buyuk, Basak |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Revista da Associacao Medica Brasileira (1992) |d 1997 |g 65(2019), 2 vom: 14. Feb., Seite 183-190 |w (DE-627)NLM012880094 |x 1806-9282 |7 nnns |
773 | 1 | 8 | |g volume:65 |g year:2019 |g number:2 |g day:14 |g month:02 |g pages:183-190 |
856 | 4 | 0 | |u http://dx.doi.org/10.1590/1806-9282.65.2.183 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 65 |j 2019 |e 2 |b 14 |c 02 |h 183-190 |